ABERDEEN LIFE SCIENCES INVESTORS (HQL) 주가

ABERDEEN LIFE SCIENCES INVESTORS(HQL)는 NYS에 상장된 Financial Services · Asset Management 기업입니다. 현재가 $19.41 (-0.82%), 시가총액 $537.01M, PER 6.33.

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies.

핵심 지표

• 현재가: $19.41 (-0.82%)
• 시가총액: $537.01M
• PER (주가수익비율): 6.33
• 섹터: Financial Services
• 산업: Asset Management
• 거래소: NYS

ABERDEEN LIFE SCIENCES INVESTORS의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

ABERDEEN LIFE SCIENCES INVESTORS 재무 요약

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 1.05
• 영업이익률: -346.83%
• 배당수익률: 10.45%

자주 묻는 질문